January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This research abstract outlines that in general practice, androgenic alopecia is diagnosed through clinical evaluation, with management strategies focusing on stopping disease progression and promoting hair regrowth using validated topical and oral treatments.
September 2025 in “International Journal of Molecular Sciences” This article provides a clinical update on alopecia areata, highlighting the disease's multifactorial causes, challenges it presents, and the current treatment options, with a focus on comparing international guidelines and discussing comorbidities.
July 2025 in “The Lancet Regional Health - Southeast Asia” This Health Policy report outlines the creation of evidence-based clinical practice guidelines and referral pathways for managing dermatological conditions in Pakistan's primary care setting, aiming to standardize care and improve patient outcomes.
July 2025 in “Indian Journal of Endocrinology and Metabolism” This source provides a comprehensive guideline for the management of transgender individuals in India, highlighting the need for multidisciplinary diagnosis, counseling for gender-affirming hormone therapy, and the importance of addressing social stigma, legal issues, and medical training to improve healthcare access for this population.
This study concluded that patients with alopecia areata receiving Janus kinase inhibitors are not maintaining the recommended frequency of lab monitoring every three months, indicating a need for new strategies to improve adherence.
August 2024 in “The Journal of Urology” This study updates guidelines for evaluating and managing male infertility, including revised testing recommendations for Y-chromosome microdeletions, use of pelvic MRI, and testicular sperm in nonazoospermic males.
No results were reported in this guideline paper, which was authored by the Task Force for Guidelines for Virtual Consultations of the ISHRS to provide suggestions on effectively offering virtual consultations in hair restoration practice.
November 2010 in “Value in Health” Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.
January 2016 in “China Medical Abstracts(Dermatology)” This article outlines diagnosis and treatment guidelines for androgenetic alopecia but reports no new clinical findings.
2170 citations
,
September 2017 in “The Journal of Clinical Endocrinology & Metabolism” This updated guideline from the Endocrine Society highlights the importance of endocrinologists in providing safe and effective hormone regimens for gender-affirming care, especially for adolescents who have entered puberty.
April 2026 in “University of Southern Denmark Research Portal (University of Southern Denmark)”
18 citations
,
October 2015 in “Journal of the European Academy of Dermatology and Venereology” This assessment of European Dermatology Forum guidelines found varying methodological quality, with S3 guidelines scoring highest overall, highlighting a need for standardization in guideline development.
11 citations
,
August 2023 in “Regenerative Therapy” This study proposes a reporting guideline, CLINIC - STRA-SVF, to standardize and improve the design and reporting of clinical studies involving SVF, highlighting its safety and effectiveness despite the low level of current evidence.
8 citations
,
August 2023 in “The Journal of Clinical Endocrinology and Metabolism” This study provided updated international guidelines for assessing and managing polycystic ovary syndrome, emphasizing evidence-based recommendations and acknowledging the low to moderate quality of existing evidence.
6 citations
,
August 2023 in “Fertility and Sterility” This review details the 2023 International Guideline update for assessing and managing polycystic ovary syndrome, which provides evidence-based recommendations to improve care and patient outcomes but notes the remaining low to moderate quality of evidence.
4 citations
,
January 2018 in “Journal of dermatology & dermatologic surgery” This review compares European and U.S. treatment guidelines for hidradenitis suppurativa and reports no definitive standard, highlighting the need for more randomized controlled trials.
This study highlights that vitiligo, a pigmentary disorder affecting 0.52% of the global population, significantly impacts patients' self-image and quality of life, with many seeking cosmetic dermatology procedures for aesthetic improvement.
December 2025 in “npj Breast Cancer” In the phase 3 CAPItello-291 trial, capivasertib combined with fulvestrant significantly increased progression-free survival in patients with advanced breast cancer with specific genetic alterations, but the authors highlight that managing side effects like diarrhea, rash, and hyperglycemia is crucial for optimizing treatment adherence and outcomes.
September 2023 in “Journal of the American Academy of Dermatology” This study examined the application of new clinical guidelines for diagnosing frontal fibrosing alopecia in 18 men, highlighting that current diagnostic criteria may often overlook early beard involvement and sideburn recession.
January 2020 in “Integrative Medicine Research” 3 citations
,
May 2025 in “Clinical Endocrinology” Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.
2 citations
,
August 2023 in “Human Reproduction” This update of the 2023 International Guideline for PCOS offers refined diagnostic criteria and management recommendations, emphasizing evidence-based care, but notes that research quality remains low to moderate.
36 citations
,
December 2016 in “Journal of The American Academy of Dermatology” In this study, researchers evaluated the hair pull test and found that normal values should be reduced to two hairs or fewer, with no significant impact from hair washing, brushing, or lifestyle factors such as hair texture and medication use.
16 citations
,
January 2011 in “Indian Journal of Dermatology, Venereology and Leprology” This article discusses various infection control practices necessary in dermatology to minimize exogenous infection risk and reports no new clinical results.
11 citations
,
December 2024 in “Wound Repair and Regeneration” In this study, researchers created the WRAHPS Guidelines to standardize the reporting of preclinical wound healing studies, aiming to improve transparency, enable comparative analysis, and support the development of human clinical trials for wound healing disorders.
7 citations
,
January 2023 in “Anti-Cancer Drugs” In this study, researchers reviewed cases of EGFR inhibitor-induced folliculitis decalvans and reported the first known occurrences associated with afatinib in three female NSCLC patients, highlighting the importance of early diagnosis and management to improve patient quality of life.
2 citations
,
February 2025 in “Journal of the American Pharmacists Association” This study identified key content for pharmacy professionals' education on handling cytotoxic drugs, highlighting training in aseptic techniques, PPE use, and spill management, and recommended developing guidelines with both theoretical and practical learning components to enhance their implementation.
April 2026 in “Italian Journal of Dermatology and Venereology” September 2025 in “Headache The Journal of Head and Face Pain” In this critique, the authors argue that the American College of Physicians' recent guideline for migraine preventive therapy is based on a flawed analysis with low confidence levels and outdated data, failing to acknowledge newer migraine-specific therapies with stronger evidence and better tolerability.
September 2022 in “Medical Herald of the South of Russia” This article discusses the effectiveness of gender transition procedures in alleviating gender dysphoria and the need for better models to understand their mechanisms, but reports no new clinical results.